Karin Schilbach

2.3k total citations
45 papers, 1.1k citations indexed

About

Karin Schilbach is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Karin Schilbach has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Immunology, 19 papers in Oncology and 11 papers in Hematology. Recurrent topics in Karin Schilbach's work include Immune Cell Function and Interaction (22 papers), T-cell and B-cell Immunology (22 papers) and Immunotherapy and Immune Responses (16 papers). Karin Schilbach is often cited by papers focused on Immune Cell Function and Interaction (22 papers), T-cell and B-cell Immunology (22 papers) and Immunotherapy and Immune Responses (16 papers). Karin Schilbach collaborates with scholars based in Germany, United States and United Kingdom. Karin Schilbach's co-authors include Rupert Handgretinger, D. Niethammer, Daniel Zips, Franziska Eckert, Matthias Eyrich, Stephan M. Huber, Paul G. Schlegel, Hans‐Jörg Bühring, Lukas Klumpp and Michael Schumm and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and Science Advances.

In The Last Decade

Karin Schilbach

44 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karin Schilbach Germany 21 621 517 274 253 105 45 1.1k
Simon Völkl Germany 23 461 0.7× 392 0.8× 340 1.2× 144 0.6× 110 1.0× 58 1.0k
Tim Luetkens United States 23 718 1.2× 658 1.3× 469 1.7× 416 1.6× 73 0.7× 57 1.4k
Donald Wong United States 16 553 0.9× 731 1.4× 316 1.2× 201 0.8× 75 0.7× 28 1.1k
Felix S. Lichtenegger Germany 18 698 1.1× 684 1.3× 428 1.6× 440 1.7× 103 1.0× 35 1.3k
Jasmin Wellbrock Germany 20 647 1.0× 494 1.0× 494 1.8× 219 0.9× 82 0.8× 56 1.3k
Alice Pievani Italy 14 500 0.8× 440 0.9× 205 0.7× 267 1.1× 149 1.4× 34 917
Jutta Goldschmitt Germany 10 414 0.7× 422 0.8× 234 0.9× 125 0.5× 53 0.5× 15 889
Grzegorz Terszowski Switzerland 15 562 0.9× 277 0.5× 279 1.0× 112 0.4× 134 1.3× 23 1.1k
Brandon Harder United States 14 634 1.0× 332 0.6× 372 1.4× 246 1.0× 172 1.6× 19 1.4k
Aniruddha Choudhury Sweden 20 1.2k 1.9× 909 1.8× 460 1.7× 192 0.8× 166 1.6× 38 1.7k

Countries citing papers authored by Karin Schilbach

Since Specialization
Citations

This map shows the geographic impact of Karin Schilbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Schilbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Schilbach more than expected).

Fields of papers citing papers by Karin Schilbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Schilbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Schilbach. The network helps show where Karin Schilbach may publish in the future.

Co-authorship network of co-authors of Karin Schilbach

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Schilbach. A scholar is included among the top collaborators of Karin Schilbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Schilbach. Karin Schilbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yao, Matthias Eyrich, Hisayoshi Hashimoto, et al.. (2025). Iron overload in HFE-related hemochromatosis severely impairs Vδ2+ γδ T-cell homeostasis. Blood. 146(2). 219–232. 1 indexed citations
2.
Hashimoto, Hisayoshi, et al.. (2022). TH1 cytokines induce senescence in AML. Leukemia Research. 117. 106842–106842. 6 indexed citations
3.
Schilbach, Karin, Derya Güngör, Elke Malenke, et al.. (2021). Somatic Reversion of a Novel IL2RG Mutation Resulting in Atypical X-Linked Combined Immunodeficiency. Genes. 13(1). 35–35. 8 indexed citations
4.
Hashimoto, Hisayoshi, et al.. (2021). Removal of CD276+ cells from haploidentical memory T-cell grafts significantly lowers the risk of GVHD. Bone Marrow Transplantation. 56(10). 2336–2354. 8 indexed citations
5.
Wesch, Daniela, Hans‐Heinrich Oberg, Christian Peters, et al.. (2020). Pitfalls in the characterization of circulating and tissue-resident human γδ T cells. Journal of Leukocyte Biology. 107(6). 1097–1105. 11 indexed citations
6.
Schilbach, Karin, et al.. (2020). Suppressive activity of Vδ2+ γδ T cells on αβ T cells is licensed by TCR signaling and correlates with signal strength. Cancer Immunology Immunotherapy. 69(4). 593–610. 19 indexed citations
8.
Schilbach, Karin, Ursula Holzer, Jens Schittenhelm, et al.. (2019). Allogeneic hematopoietic stem cell transplantation in two brothers with DNA ligase IV deficiency: a case report and review of the literature. BMC Pediatrics. 19(1). 346–346. 9 indexed citations
9.
Eckert, Franziska, Karin Schilbach, Lukas Klumpp, et al.. (2018). Potential Role of CXCR4 Targeting in the Context of Radiotherapy and Immunotherapy of Cancer. Frontiers in Immunology. 9. 3018–3018. 98 indexed citations
10.
Eckert, Franziska, Ivan Jelas, Stephan M. Huber, et al.. (2017). Tumor-targeted IL-12 combined with local irradiation leads to systemic tumor control via abscopal effects in vivo. OncoImmunology. 6(6). e1323161–e1323161. 41 indexed citations
11.
Seitz, Christian, Patrick Schlegel, Sarah M. Schroeder, et al.. (2017). Novel Adapter Chimeric Antigen Receptor (aCAR) T Cells for Temporally Controllable Targeting of Single and Multiple Tumor Antigens. Blood. 130. 1912–1912. 3 indexed citations
12.
Sipos, Bence, Franziska Eckert, Christian Seitz, et al.. (2015). Preemptive administration of human αβ T cell receptor-targeting monoclonal antibody GZ-αβTCR potently abrogates aggressive graft-versus-host disease in vivo. Annals of Hematology. 94(11). 1907–1919. 6 indexed citations
13.
Haarer, Jan, et al.. (2014). Human Peripheral CD4+ Vδ1+ γδT Cells Can Develop into αβT Cells. Frontiers in Immunology. 5. 645–645. 21 indexed citations
14.
Feldhahn, Magdalena, Pierre Dönnes, Benjamin Schubert, et al.. (2012). miHA-Match: Computational detection of tissue-specific minor histocompatibility antigens. Journal of Immunological Methods. 386(1-2). 94–100. 4 indexed citations
15.
Schilbach, Karin, et al.. (2008). Immune Response of Human Propagated γδ-T-Cells to Neuroblastoma Recommend the Vδ1+ Subset for γδ-T-cell–based Immunotherapy. Journal of Immunotherapy. 31(9). 896–905. 27 indexed citations
16.
Eyrich, Matthias, Klaus Dietz, Peter Bader, et al.. (2005). Onset of thymic recovery and plateau of thymic output are differentially regulated after stem cell transplantation in children. Biology of Blood and Marrow Transplantation. 11(3). 194–205. 37 indexed citations
18.
Schilbach, Karin, Hermann Kreyenberg, A Geiselhart, D. Niethammer, & Rupert Handgretinger. (2004). Cloning of a human antibody directed against human neuroblastoma cells and specific for human translation elongation factor 1α. Tissue Antigens. 63(2). 122–131. 7 indexed citations
19.
Schilbach, Karin, Peter Pollwein, M. Schwab, et al.. (1990). Reduction of N-myc expression by antisense RNA is amplified by interferon: Possible involvement of the 2-5A system. Biochemical and Biophysical Research Communications. 170(3). 1242–1248. 7 indexed citations
20.
Bruchelt, Gernot, et al.. (1987). Methods for the Determination of the Interferon-Induced Enzyme 2'-5' Oligoadenylate Synthetase in Mononuclear Blood Cells. Clinical Chemistry and Laboratory Medicine (CCLM). 25(12). 879–88. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026